Term
75% pts with CF diagnosed when |
|
Definition
2 years old (Autosomal recessive disorder) |
|
|
Term
|
Definition
CFTR gene mutation Most common mutation=F508 |
|
|
Term
Patho is decreased?
Patho is increased? |
|
Definition
Decreased SECRETION OF CL & H2O
Increased REABSORPTION of Na+ |
|
|
Term
|
Definition
|
|
Term
Positive sweat chloride test for Dx |
|
Definition
|
|
Term
|
Definition
Pseudomonas -causes cough, recurrent pneumonia,mucus |
|
|
Term
|
Definition
|
|
Term
|
Definition
-Cipro
-piptazo,aminoglyc,
-ceftazidime,cefepime,
-imipenem,meropenem |
|
|
Term
Aerosols indicated in who |
|
Definition
>/=6 yrs & chronis Pseudomonas colonies |
|
|
Term
|
Definition
Tobramycin dry powder or nebulizer Aztreonam nebulizer Colistimethate nebulizer |
|
|
Term
Mucokinetics (for >/=6yrs) |
|
Definition
Hypertonic saline Dornase Alfa [Pulmozyme] Albuterol 2 puff po before inhale Tx (opens airways) |
|
|
Term
Dornase Alfa [Pulmozyme] MOA |
|
Definition
Digests extracellular DNA sputum from neutrophil breakdown |
|
|
Term
Sequence of Airway ckearing Tx |
|
Definition
Brochodilator(albuterol) Hypertionic Saline Dornase Alfa Aerosol ABXs |
|
|
Term
PO Anti inflamatory agents |
|
Definition
-AZITHRO 250-500mg po tiw -Ibuprofen 20-30mg/kg/dose bid |
|
|
Term
|
Definition
>/= 6 yrs old & chronic pseudomonas colonization |
|
|
Term
IBUprofen antiinflamm TX is for |
|
Definition
6-17 yrs old & FEV >/= 60% predicted |
|
|
Term
|
Definition
Slow loss of lung function |
|
|
Term
|
Definition
Fatty stools rectal prolappse Deficient in ADEK |
|
|
Term
|
Definition
Pancreatic Lipase -Zenpep -Creon -Pancreaze -Pertzye |
|
|
Term
|
Definition
High calorie High protein Supplement w/ ADEK Vitamins |
|
|
Term
|
Definition
10 yrs old annual OGTT test in CF related DM |
|
|
Term
|
Definition
Insulin basal and bolus combo -0.5 to 1 unit rapid insulin for q 15g of carbs |
|
|
Term
|
Definition
|
|
Term
|
Definition
>/=2yrs old w/ at least 1 CFTR mutation that is responsive {IVACAFTOR = CFTR potentiator} |
|
|
Term
KALYDECO (Ivacaftor) counseling |
|
Definition
-take w/ full meal -beware of CYP3A4 inhibitors -Monitor LFTs q 3 months for first year then annually |
|
|
Term
ORKAMBI (Ivacaftor/Lumacaftor) indicated in |
|
Definition
-F508 homozygous pts ->/=6 years -take with fatty meal |
|
|